LANGWIRKENDE GLP-1-VERBINDUNG

European patent · EP4086277 · In force

Register entry

Publication number
EP4086277
Application number
EP20909624
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 29, 2020
Published
Nov 9, 2022
Granted
Aug 26, 2026
Protection ends at the latest
Dec 28, 2040
Next annual fee due
Dec 31, 2026
IPC classes
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
A61P 3/10 (2006.01)
A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61K 47/26 (2006.01)
Priority
CN 201911397405 30.12.2019
CN 202011053306 29.09.2020
PCT application
PCT/CN2020/141057 29.12.2020
PCT publication
WO2021/136303 08.07.2021
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 26, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.08.2026

Parties

Holder

Gan & Lee Pharmaceuticals Co., Ltd.

No. 8 Nanfeng West 1st Street, Huoxian Tongzhou District, Beijing 101109, CN

Inventor

GAN, Zhongru

Beijing 101109, CN

CHEN, Wei

Beijing 101109, CN

ZHANG, Yining

Beijing 101109, CN

XUE, Fangkai

Beijing 101109, CN

CAI, Lingyu

Beijing 101109, CN

NIU, Jianghong

Beijing 101109, CN

MU, Bin

Beijing 101109, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.